Tolvaptan for the Treatment of Enlarged Polycystic Liver Disease

A 44-year-old Japanese woman with autosomal dominant polycystic kidney disease was admitted to our hospital for evaluation of abdominal distension. Her eGFR was 53.7 mL/min/1.73 m(2). Total kidney volume was 2,614 mL. Tolvaptan (60 mg/day) was started to treat renal involvement. The patient's a...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Case Rep Nephrol Dial
Glavni autori: Mizuno, Hiroki, Hoshino, Junichi, Suwabe, Tatsuya, Sumida, Keiichi, Sekine, Akinari, Oshima, Yoichi, Oguro, Masahiko, Kunizawa, Kyohei, Kawada, Masahiro, Hiramatsu, Rikako, Hayami, Noriko, Hasegawa, Eiko, Yamanouchi, Masayuki, Sawa, Naoki, Takaichi, Kenmei, Ubara, Yoshifumi
Format: Artigo
Jezik:Inglês
Izdano: S. Karger AG 2017
Teme:
Case Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5624279/
https://ncbi.nlm.nih.gov/pubmed/29034246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000477664
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items